MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1086/651561

Медицинская библиотека · The Journal of infectious diseases · 2010

Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.

Wilck Marissa B, Seaman Michael S, Baden Lindsey R, Walsh Stephen R, Grandpre Lauren E, Devoy Colleen, Giri Ayush, Kleinjan Jane A, Noble Lizanne C, Stevenson Kristen E, Kim Haesook T, Dolin Raphael

СтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

We conducted a clinical trial of the safety and immunogenicity of modified vaccinia Ankara (MVA) to examine the effects of dose and route of administration.

METHODS

Seventy-two healthy, vaccinia virus-naive subjects received 1 of 6 regimens of MVA (ACAM3000) or placebo consisting of 2 administrations given 1 month apart.

RESULTS

MVA was generally well tolerated at all dose levels and by all routes. More pronounced local reactogenicity was seen with the intradermal and subcutaneous routes than with intramuscular administration. Binding antibodies to whole virus and neutralizing antibodies to the intracellular mature virion and extracellular enveloped virion forms of vaccinia virus were elicited by all routes of MVA administration and were greater for the higher dose by each route. Similar levels of neutralizing antibodies were seen at a 10-fold-lower dose given intradermally (1 x 10(7) median tissue culture infective doses [TCID(50)]), compared with responses after 1 x 10(8) TCID(50) given intramuscularly or subcutaneously. T cell immune responses to vaccinia virus were detected by an interferon gamma enzyme-linked immunospot assay but had no clear relationship to dose or route.

CONCLUSIONS

These data suggest that intradermal immunization with MVA provides a dose-sparing effect by eliciting antibody responses similar in magnitude and kinetics to those elicited by the intramuscular or subcutaneous routes but at a 10-fold-lower dose.

Для цитирования: Wilck Marissa B, Seaman Michael S, Baden Lindsey R, Walsh Stephen R, Grandpre Lauren E, Devoy Colleen, Giri Ayush, Kleinjan Jane A, Noble Lizanne C, Stevenson Kristen E, Kim Haesook T, Dolin Raphael. Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.. The Journal of infectious diseases. 2010. DOI: 10.1086/651561.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.